Phil Shackley BA MSc PhD

Senior Lecturer in Health Economics

Address:
Sheffield Vascular Institute, HEDS, ScHARR
University of Sheffield
Regent Court, 30 Regent Street
Sheffield S1 4DA
UK

Office:

Tel: (+44) (0)114 222 2992
Fax: (+44) (0)114 272 4095
Room: 3030

E-mail: p.shackley@sheffield.ac.uk

Biography

I was appointed as Senior Lecturer in Health Economics in 2006, having previously held a Senior Lecturer appointment at the University of Newcastle (2002–2006). Prior to that I worked as a Lecturer at the University of Sheffield (1996–2002) and as a Research Fellow at the University of Aberdeen (1991–1996).

Research interests

• Developing and applying the contingent valuation methodology, in particular the technique of willingness to pay. Applications include: estimating the social value of a quality adjusted life year (QALY); using willingness to pay values to aid priority setting in publicly-financed health care systems; investigating how willingness to pay can and should be used alongside randomised trials; the use of willingness to pay to evaluate the benefits of public health interventions such as the fluoridation of drinking water supplies and the supplementation of flour with folic acid; evaluating minimally invasive surgery; assessing patient preferences for diagnostic radiology; and assessing preferences for an expanded newborn screening programme.
  
  
• The identification, measurement and valuation of (dis)benefits that are not captured in the QALY approach. Applications include: assessing the value of patient health cards; eliciting patient preferences for out-of-hours primary care services; establishing and quantifying the preferences of mental health service users for day hospital care; eliciting patient preferences for the organisation of vascular services; and assessing preferences for access to a general practitioner.
  
  
• The application of economic evaluation techniques to assess the efficiency of health care programmes and interventions. Applications include: screening in primary care; antenatal screening; management of lower respiratory tract infection in general practice; computerised cognitive behavioural therapy for anxiety and depression; methods for assessing patients with intermittent claudication; drug treatments for epilepsy; stroke incidence and prevention in Tanzania; venous leg ulcers; and treating upper limb spasticity due to stroke with botulinum toxin.
  
  

Teaching Interests

I teach health economics on a number of modules across ScHARR's suite of masters' courses. I am the Course Director of the MSc in Health Economics and Decision Modelling and Deputy Director of Teaching and Learning for ScHARR (HEDS).

Professional Activities

• Member of the Higher Education Academy (formerly the Institute for Learning and Teaching in Higher Education)
• Member of the UK Health Economists' Study Group
• Member of the International Health Economics Association

Current Projects

• National Institute for Health Research: Systematic review and modelling of the cost effectiveness of Cardiac Magnetic Resonance Imaging compared to current existing testing pathways in cardiac disease (2011 - 2012). £142,000.
• Department of Health: Enhancement to angioplasty for peripheral arterial occlusive disease (PAOD) systematic review, cost effectiveness assessment and expected value of information (2010 - 2012). £268,000.
• Devices for Dignity: Valuing dignity (2010 - 2012). £54,000.

Key Publications

• Dixon S., Shackley P., Bonham J. and Ibbotson R. (2011).  Putting a value on the avoidance of false positive results when screening for inherited metabolic diseases in the newborn.  Journal of Inherited Metabolic Diseases, DOI 10.1007/s10545-011-9354-0.

• Donaldson C., Baker R., Mason H., Jones-Lee M., Lancsar E., Wildman J., Bateman I., Loomes G., Robinson A., Sugden R., Pinto Prades J.L, Ryan M., Shackley P. and Smith R. (2011).  The social value of a QALY: raising the bar or barring the raise? BMC Health Services Research, 11(8).

• Shaw L., Rodgers H., Price C., van Wijck F., Shackley P., Steen N., Barnes M., Ford G., and Graham L. (2011). Botulinum Toxin for Upper Limb after Stroke (BoTULS) Trial: effect upon impairment, activity limitations and pain. Stroke, 42, 1371-1379.

• Palfreyman S., Brazier J. and Shackley P. (2010). Assessing current health related quality of life questionnaires administered to patients with venous ulcers: can they be used in economic evaluations? Journal of Clinical Nursing, 19, 892-897.

• Michaels J.A., Campbell B., King B., Palfreyman S.J., Shackley P. and Stevenson M. (2009). A randomised controlled trial and cost-effectiveness analysis of silver donating antimicrobial dressings for venous leg ulcers: the VULCAN trial. British Journal of Surgery, 96(10), 1147-1156.

Section

Phil Shackley is based in Health Economics and Decision Science (HEDS).